4ArrayExpress Uploader0humanPsoriasis treatment1803psoriasis patientsweek 2, after ixekizumab 150mg subcutaneous treatmentPsoriasis treatment1710psoriasis patientsweek 2, after ixekizumab 150mg subcutaneous treatmentPsoriasis treatment1615psoriasis patientsweek 2, after ixekizumab 150mg subcutaneous treatmentPsoriasis treatment1611psoriasis patientsweek 2, after ixekizumab 150mg subcutaneous treatmentPsoriasis treatment1209psoriasis patientsweek 2, after ixekizumab 150mg subcutaneous treatmentPsoriasis treatment1208psoriasis patientsweek 2, after ixekizumab 150mg subcutaneous treatmentPsoriasis treatment1207psoriasis patientsweek 2, after ixekizumab 150mg subcutaneous treatmentPsoriasis Baseline1803psoriasis patientsbaseline; before treatmentPsoriasis Baseline1710psoriasis patientsbaseline; before treatmentPsoriasis Baseline1615psoriasis patientsbaseline; before treatmentPsoriasis Baseline1611psoriasis patientsbaseline; before treatmentPsoriasis Baseline1610psoriasis patientsbaseline; before treatmentPsoriasis Baseline1209psoriasis patientsbaseline; before treatmentPsoriasis Baseline1208psoriasis patientsbaseline; before treatmentPsoriasis Baseline1207psoriasis patientsbaseline; before treatmentPsoriasis Baseline1902psoriasis patientsbaseline; before treatmentPsoriasis Baseline1707psoriasis patientsbaseline; before treatmentPsoriasis Baseline1706psoriasis patientsbaseline; before treatmentPsoriasis Baseline1612psoriasis patientsbaseline; before treatmentPsoriasis Baseline1609psoriasis patientsbaseline; before treatmentPsoriasis Baseline1608psoriasis patientsbaseline; before treatmentPsoriasis Baseline1607psoriasis patientsbaseline; before treatmentPsoriasis Baseline1109psoriasis patientsbaseline; before treatmentPsoriasis Baseline1801psoriasis patientsbaseline; before treatmentPsoriasis Baseline1606psoriasis patientsbaseline; before treatmentPsoriasis Baseline1505psoriasis patientsbaseline; before treatmentPsoriasis Baseline1410psoriasis patientsbaseline; before treatmentPsoriasis Baseline1404psoriasis patientsbaseline; before treatmentPsoriasis Baseline1403psoriasis patientsbaseline; before treatmentPsoriasis Baseline1402psoriasis patientsbaseline; before treatmentPsoriasis Baseline1401psoriasis patientsbaseline; before treatmentPsoriasis Baseline1605psoriasis patientsbaseline; before treatmentPsoriasis Baseline1504psoriasis patientsbaseline; before treatmentPsoriasis Baseline1502psoriasis patientsbaseline; before treatmentPsoriasis Baseline1303psoriasis patientsbaseline; before treatmentPsoriasis Baseline1301psoriasis patientsbaseline; before treatmentPsoriasis Baseline1104psoriasis patientsbaseline; before treatmentPsoriasis Baseline1102psoriasis patientsbaseline; before treatmentPsoriasis Baseline1604psoriasis patientsbaseline; before treatmentPsoriasis Baseline1603psoriasis patientsbaseline; before treatmentPsoriasis Baseline1602psoriasis patientsbaseline; before treatmentPsoriasis Baseline1601psoriasis patientsbaseline; before treatmentPsoriasis Baseline1205psoriasis patientsbaseline; before treatmentPsoriasis Baseline1702psoriasis patientsbaseline; before treatmentPsoriasis Baseline1614psoriasis patientsbaseline; before treatmentPsoriasis Baseline1613psoriasis patientsbaseline; before treatmentPsoriasis Baseline1507psoriasis patientsbaseline; before treatmentPsoriasis Baseline1503psoriasis patientsbaseline; before treatmentPsoriasis Baseline1405psoriasis patientsbaseline; before treatmentPsoriasis Baseline1304psoriasis patientsbaseline; before treatmentPsoriasis Baseline1108psoriasis patientsbaseline; before treatmentHealthy Control11855healthy volunteernot specifiedHealthy Control11854healthy volunteernot specifiedHealthy Control11853healthy volunteernot specifiedHealthy Control11852healthy volunteernot specifiedHealthy Control11851healthy volunteernot specifiedHealthy Control11850healthy volunteernot specifiedHealthy Control11849healthy volunteernot specifiedHealthy Control11848healthy volunteernot specifiedHealthy Control11847healthy volunteernot specifiedHealthy Control11846healthy volunteernot specifiedHealthy Control11824healthy volunteernot specifiedHealthy Control11823healthy volunteernot specifiedHealthy Control11822healthy volunteernot specifiedHealthy Control11821healthy volunteernot specifiedHealthy Control11820healthy volunteernot specifiedHealthy Control11819healthy volunteernot specifiedHealthy Control11818healthy volunteernot specifiedHealthy Control11817healthy volunteernot specifiedHealthy Control11816healthy volunteernot specifiedHealthy Control11815healthy volunteernot specifiedHealthy Control11699healthy volunteernot specifiedHealthy Control11698healthy volunteernot specifiedHealthy Control11697healthy volunteernot specifiedHealthy Control11696healthy volunteernot specifiedHealthy Control11695healthy volunteernot specifiedHealthy Control11694healthy volunteernot specifiedHealthy Control11693healthy volunteernot specifiedHealthy Control11692healthy volunteernot specifiedHealthy Control11691healthy volunteernot specifiedHealthy Control11690healthy volunteernot specified2081arrayexpress_sidhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-55201The effect of anti-IL-17 treatment on systemic inflammation is not fully understand. Using cDNA microarray, genomic analysis methods such.../profile/8773/arrayexpressuploader481psoriasisDec.12, 2014FalseE-GEOD-55201_A-AFFY-44suppression-of-inflammation-in-psoriasis-blood-aftSuppression of inflammation in psoriasis blood after IL-17 treatment with ixekizumabJul.11, 2014The effect of anti-IL-17 treatment on systemic inflammation is not fully understand. Using cDNA microarray, genomic analysis methods such as GSEA and ingenuity, we characterized the transcriptional changes in the blood of psoriasis patients afer systemic neutralization of IL-17 compared to baseline (before treatment). We also compared the whole blood-derived transcriptome between psoraisis patients at baseline and healthy volunteers to examine systemic inflammation in psoriasis patients. total RNA was extratced from whole blood from psoriasis patients at baseline and after two weeks of treatment; total RNA was extracted from the whole blood of healthy individualsE-GEOD-55201http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-55201/samples/